A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022 *

; 2022 ASCO Annual Meeting, June 3-7, 2022, in Chicago, Illinois, USA; EHA 2022 Congress, June 9-12, 2022, in Vienna, Austria; 2022 Pan Pacific Lymphoma Conference, July 18-22, 2022, in Koloa, Hawaii, USA; ESMO 2022 Annual Congress, September 9-13, 2022, in Paris, France; 2022 SOHO Annual Meeting, September 28 - October 1, 2022, in Houston, Texas, USA
Get up to date on emerging data with BTK inhibitors for chronic lymphocytic leukemia and mantle cell lymphoma presented at the 2022 meetings of ASCO, EHA, Pan Pacific Lymphoma, ESMO, and SOHO with on-demand webcasts, expert podcasts, downloadable slides, commentaries, and a “year in review” module.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Lilly

*PCE is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.